Association in univariate analyses between clinical findings and the presence of Neisseria gonorrhoeae (NG), Chlamydia trachomatis (CT), Mycoplasma genitalium (MG) or Trichomomas vaginalis (TV) among sex workers in Ghana and Bénin. The baseline category consists of FSW who were negative for NG, CT, MG, and TV
| NG− CT− MG− TV− | NG+ | OR (95% CI) | CT+ | OR (95% CI) | MG+ | OR (95% CI) | TV+ | OR (95% CI) | |
|---|---|---|---|---|---|---|---|---|---|
| *p<0.05; **p<0.001. | |||||||||
| †Presence of a yellow cervical exudate (“swab test”). | |||||||||
| Cervical discharge | |||||||||
| Yes | 32 (7.8%) | 43 (32.8%) | 5.7 (3.3 to 10.0)** | 11 (39.3%) | 7.6 (3.0 to 19.1)** | 38 (17.5%) | 2.5 (1.5 to 4.3)** | 34 (17.9%) | 2.6 (1.5 to 4.5)** |
| No | 376 | 88 | 17 | 179 | 156 | ||||
| Pus on cervical swab† | |||||||||
| Yes | 28 (7.2%) | 41 (34.5%) | 6.8 (3.8 to 12.2)** | 8 (32.0%) | 6.1 (2.2 to 16.9)** | 34 (16.5%) | 2.6 (1.5 to 4.5)** | 30 (16.9%) | 2.6 (1.5 to 4.8)** |
| No | 363 | 78 | 17 | 172 | 147 | ||||
| Bleeding after sampling | |||||||||
| Yes | 13 (3.2%) | 29 (22.1%) | 8.7 (4.1 to 18.4)** | 4 (14.3%) | 5.1 (1.3 to 18.8)* | 26 (12.0%) | 4.2 (2.0 to 8.8)** | 24 (12.6%) | 4.4 (2.1 to 9.45)** |
| No | 396 | 102 | 24 | 190 | 166 | ||||
| Inflammatory cervix | |||||||||
| Yes | 36 (8.8%) | 41 (31.5%) | 4.8 (2.8 to 8.2)** | 7 (25.0%) | 3.4 (1.2 to 9.4)* | 40 (18.6%) | 2.4 (1.4 to 4.0)** | 33 (17.4%) | 2.2 (1.3 to 3.7)* |
| No | 372 | 89 | 21 | 175 | 157 | ||||
| Cervical motion tenderness | |||||||||
| Yes | 43 (10.5%) | 37 (28.2%) | 3.4 (2.0 to 5.7)** | 7 (25.0%) | 2.8 (1.0 to 7.7)* | 39 (18.0%) | 1.9 (1.1 to 3.1)* | 32 (16.8%) | 1.7 (1.0 to 2.9)* |
| No | 366 | 94 | 21 | 178 | 158 | ||||
| Number of signs above | |||||||||
| 0 | 331 (84.7%) | 62 (52.1%) | 1.0 | 14 (56.0%) | 1.0 | 143(69.4%) | 1.0 | 127(71.8%) | 1.0 |
| 1 | 14 (3.6%) | 6 (5.0%) | 2.3 (0.8 to 6.2) | 2 (8.0%) | 3.4 (0.7 to 16.4) | 10 (4.9%) | 1.7 (0.7 to 3.8) | 10 (5.6%) | 1.9 (0.8 to 4.3) |
| 2 | 16 (4.1%) | 10 (8.4%) | 3.3 (1.4 to 7.8)* | 2 (8.0%) | 3.0 (0.6 to 14.2) | 20 (9.7%) | 2.9 (1.4 to 5.8)* | 10 (5.6%) | 1.6 (0.7 to 3.7) |
| 3 to 5 | 30 (7.7%) | 41 (34.5%) | 7.3(4.1 to 13.1)** | 7 (28.0%) | 5.5 (2.0 to 15.0)** | 33(16.0%) | 2.5 (1.5 to 4.4)** | 30 (16.9%) | 2.6 (1.5 to 4.5)** |
| Vaginal discharge | |||||||||
| Yes | 69 (16.8%) | 37 (28.0%) | 1.9 | 10 (35.7%) | 2.75 (1.1 to 6.7)* | 53 (24.4%) | 1.6 (1.0 to 2.45)* | 46 (24.1%) | 1.6 (1.0 to 2.45)* |
| No | 341 | 95 | (1.2 to 3.1)* | 18 | 164 | 145 | |||